Evidence map›Paper›PMID 23892589›Full record

ArticleThe Journal of investigative dermatology2014

c-Rel downregulation affects cell cycle progression of human keratinocytes.

Verena N Lorenz, Michael P Schön, Cornelia S Seitz

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Signaling pathways and targeted therapies for psoriasis.Signal transduction and targeted therapy · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. [Pathogenesis of psoriasis].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2016
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Verena N LorenzDepartment of Dermatology, Venereology and Allergology, Georg August University Göttingen, Göttingen, Germany.
Michael P SchönDepartment of Dermatology, Venereology and Allergology, Georg August University Göttingen, Göttingen, Germany.
Cornelia S SeitzDepartment of Dermatology, Venereology and Allergology, Georg August University Göttingen, Göttingen, Germany. Electronic address: cseitz@med.uni-goettingen.de.
University of Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The c-Rel protein, a member of the NF-κB transcription factor family, exerts unique and distinctive functions in various cell types. Although c-Rel is expressed in human epidermis, its functions in keratinocytes are poorly understood. Our small interfering RNA-based approach of c-Rel silencing in HaCaT keratinocytes induced altered cell morphology toward a spindle-shaped appearance. In addition, c-Rel downregulation resulted in increased apoptosis and significantly reduced proliferation towing to G2/M cell cycle delay, concomitant aberrant mitotic spindle formation, and induction of phospho-aurora A(Thr288). The relevance of c-Rel in epithelial carcinogenesis was further supported by detection of c-Rel expression in squamous cell carcinomas of the skin. Our studies indicate that c-Rel is a key regulator of cell fate decisions in keratinocytes such as cell growth and death and may have a role in epidermal carcinogenesis.

Indexed as

ApoptosisBowen's DiseaseCarcinoma, Squamous CellCell CycleCell DivisionCell Line, TransformedDNA-Binding ProteinsDown-RegulationEpidermal CellsEpidermisG2 PhaseHumansKeratinocytesKeratosis, ActinicNuclear ProteinsProto-Oncogene Proteins c-relDNA-Binding ProteinsNuclear ProteinsProto-Oncogene Proteins c-relREL protein, humanRNA, Small Interfering

Identifiers

PMID23892589
OpenAlexW1990773604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.